Help your clinicians stay up to date with the most current COVID – 19 information – Click here for details

Stay up to date with Coronavirus

If you are experiencing serious anxiety or mental distress or need assistance you may reach out for mental help from the CDC By calling:
1800-985-5990 or by texting TalkWithUs to 66746

Blast Announcements from TMA

COVID – 19 Announcement – 3-16-2020

Sign-on letters

Through our coalition partnerships TMA is advocating on your behalf to ensure that patient and care partner needs are being met during this time. 

AAPD COVID 19 Civil Rights Letter
Include People with Disabilities in the COVID-19 Response 

American Association of People with Disabilities
Final disability priorities coalition letter

Buy American
Letter to President Trump

Letters to Governors Highlighting
Access Barriers During COVID 19

Rare Disease Patient Community Outreach to CMS
Anticipation of Nation Reopening

Centers for Medicare and Medicaid Services
CMS Medicaid NPRM


Dr. Rohit Aggarwal, MD, MS
TMA’s Medical Advisory Board, Chair

  • COVID – 19Is a pandemic by World Health Organization (WHO)
  • COVID – 19 and Immunosuppressive drugs Answers questions on COVID 19 especially related to immunosuppressive drugs
  • Chloroquine and Hydroxychloroquine use in COVID-19 – This video discusses
    • What an anti-malarial is
    • Evidence behind these effectiveness of these drugs and how they work
    • The potential side-effects of these drugs
    • Discussion on its potential uses for prevention of COVID-19
  • All you need to know about Masks in Covid 19 – In this video Dr. Rohit Aggarwal talks about 5 key questions about the mask in Covid-19 crisis:  
    • (a)Why masks are important?
    • (b) What are the different types of masks?
    • (c)How to properly use and re-use the mask?
    • (d)What is the evidence behind the mask?
    • (e) Should we use the mask all times in all places? The best strategy to prevent Covid-19 infection


March 20, 2020
March 3, 2020

On The Web

NIH Coronavirus Page

Get the latest information about research underway to study and address the COVID-19 viral threat, including more than 300 clinical trials studying symptoms, testing, possible vaccines, and possible treatments (e.g., remdesivir, chloroquine, hydroxychloroquine). Click here

FDA Revokes Emergency Use Authorization (EUA) for emergency use of oral formulations of chloroquine phosphate (CQ) and hydroxychloroquine sulfate (HCQ)

FDA has concluded that…it is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19, nor is it reasonable to believe that the known and “potential benefits of these products outweigh their known and potential risks. Accordingly, FDA revokes the EUA for emergency use of HCQ and CQ to treat COVID-19.  For More information read the full letter here